• 1
    Cannistra SA. Cancer of the ovary. N Eng J Med 2004; 351: 251929.
  • 2
    Auersperg N,Wong A,Choi K,Kang S,Leung P. Ovarian surface epithelium: biology, endocrinology and pathology. Endocrine Reviews 2001; 22: 25588.
  • 3
    Tavassoli FA,Devilee P. Tumors of the ovary and peritoneum. In: KleihuesP,SobinL, eds. Tumors of the breast and genital organs. Lyon, France: IARC Press, 2003. 113203.
  • 4
    Auersperg N,Pan J,Grove BD,Peterson T,Fisher J,Maines-Bandiera S,Somasiri A,Roskelley CD. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA 1999; 96: 624954.
  • 5
    Daya D,McCaughy WT. Pathology of the peritoneum: a review of selected topics. Semin Diagn Pathol 1991; 8: 27789.
  • 6
    Strobel T,Swanson L,Cannistra SA. In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD 44 in the process of peritoneal implantation. Cancer Res 1997; 57: 122832.
  • 7
    Strobel TandCannistra SA. b 1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol 1999; 73: 3627.
  • 8
    Lessan K,Aguiar D,Oegema TR,Siebenson L,Skubitz AP. CD44 and b1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol 1999; 154: 152537.
  • 9
    Ahmed N,Riley C,Rice G,Quinn M. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis 2005; 22: 391402.
  • 10
    Rieppi M,Vergani V,Gatto C,Zanetta G,Allavena P,Taraboletti G,Giavazzi R. Mesothelial cells induce the motility of human ovarian carcinoma cells. Int J Cancer 1999; 80: 3037.
  • 11
    Witz C,Montoya-Rodriguez I,Cho S,Centonze V,Bonewald L,Schenken R. Composition of the extracellular matrix of the peritoneum. J Soc Gynecol Invest 2001; 8: 299304.
  • 12
    Moser TL,Pizzo SV,Bafetti L,Fishman DA,Stack MS. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the a2b1 integrin. Int J Cancer 1996; 67: 695701.
  • 13
    Wu YJ,Parker L,Binder NE,Beckett MA,Sinard JH,Griffiths CT,Rheinwald JG. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 1982; 31: 693703.
  • 14
    Zhang X,Pettengell R,Nasiri N,Kalia V,Dalgleish A,Barton D. Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources. J Soc Gynecol Invest 1999; 6: 33340.
  • 15
    Doig T,Monaghan H. Sampling the omentum in ovarian neoplasia: when one block is enough. Int J Gynecol Cancer 2006; 16: 3640.
  • 16
    Rampino T,Cancarini G,Gregorini M,Guallini P,Maggio M,Ranghino A,Soccio G,Dal Canton A. Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. Am J Pathol 2001; 159: 127585.
  • 17
    Topley N,Brown Z,Jorres A,Westwick J,Davies M,Coles GA,Williams JD. Human peritoneal mesothelial cells synthesize interleukin-8, Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J Pathol 1993 Jun; 142(6): 187686.
  • 18
    Jorres A,Ludat K,Lang J,Sander K,Gahl G,Frei U,DeJonge K,Williams JD,Topley N. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines. J Am Soc Nephrol 1996; 7: 2192201.
  • 19
    Dunfield LD,Shepherd TG,Nachtigal M. Primary culture and mRNA analysis of human ovarian cells. Biol Proc Online 2002; 4: 5561.
  • 20
    Hotary KB,Allen EB,Brooks PC,Datta NS,Long MW,Weiss SJ. Membrane Type I Matrix Metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003; 114: 3345.
  • 21
    Sawada K,Radjabi AR,Shinomiya N,Kistner E,Kenny H,Becker AR,Turkyilmaz MA,Salgia R,Yamada SD,Vande Woude GF,Tretiakova MS,Lengyel E. C-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res 2007; 67: 167080.
  • 22
    Jones L. Connective tissues and stains. In: BancroftJD,GambleM, eds. Theory and practice of histological techniques. New York: Churchill Livingstone,2002;218242.
  • 23
    Bhowmick N,Neilson E,Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 3327.
  • 24
    Bast RC,Feeney M,Lazarus H,Nadler LM,Colvin RB,Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981; 68: 13317.
  • 25
    Debnath J,Mills KR,Collins NL,Reginato MJ,Muthuswamy SK,Brugge JS. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 2002; 111: 2940.
  • 26
    Turck N,Gross I,Gendry P,Stutzmann J,Freund J,Kedinger M,Simon-Assmann P,Launay J-F. Laminin isoforms: biological roles and effects on the intracellular distribution of nuclear proteins in intestinal epithelial cells. Exp Cell Res 2005; 303: 494503.
  • 27
    Albini A,Iwamato Y,Kleinman HK,Martin GR,Aaronson SA,Kovlowski J,Mckewan RM. Rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 323945.
  • 28
    Wilkoxz S,Ireland G,Khwaja N,Walker M,Butt R,Giorgio-Miller A,Herrick S. A comparative study of the structure of human and murine greater omentum. Anat Embryol 2005; 209: 25161.
  • 29
    Sawada M,Shii J,Akedo H,Tanizawa O. An experimental model for ovarian tumor invasion of cultured mesothelial cell monolayer. Lab Invest 1994; 70: 3338.
  • 30
    Westerlund A,Hujanen E,Puistola U,Turpeenniemi-Hujanen T. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2). Gynecol Oncol 1997; 67: 7682.
  • 31
    Boyd R,Balkwill F. MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Br J Cancer 1999; 80: 31521.
  • 32
    Beningo K,Dembo M,Wanf Yu. Responses of fibroblasts to anchorage of dorsal extracellular matrix receptors. Proc Natl Acad Sci USA 2004; 101: 180249.
  • 33
    Lyengar P,Combs TP,Shah SJ,Gouon V,Pollard J,Albanase C,Flanagan L,Tenniswood MP,Guha C,Lisanti M,Pestell RG,Scherer PE. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 2003; 22: 640823.
  • 34
    Mutsaers SE. Mesothelial cells: their structure, function and role in serosal repair. Respirology 2002; 7: 17191.
  • 35
    Casey RC,Koch KA,Oegema TR,Skubitz KM,Pambuccian SE,Grindle SM,Skubitz AP. Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers. Clin Exp Metastasis 2003; 20: 34356.
  • 36
    Niedbala MJ,Crickard K,Bernacki R. Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. Exp Cell Res 1985; 160: 499513.
  • 37
    Kalluri R,Zeisberg M. Fibroblasts in cancer. Nature 2006; 6: 392401.
  • 38
    Mueller M,Fusenig N. Friends or foes—bipolar effects of the tumour stroma in cancer. Nat Rev 2004; 4: 83949.
  • 39
    Yashiro M,Chung Y,Inoue T,Nishimura S,Matsuoka T,Fujihara T,Sowa M. Hepatocyte growth factor (HGF) produced by peritoneal fibroblasts may affect mesothelial cell morphology and promote peritoneal dissemination. Int J Cancer 1996; 67: 28993.
  • 40
    Himelstein BP,Canete-Soler R,Bernhard EJ,Muschel RJ. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci 1994; 107: 47786.
  • 41
    Orimo A,Gupta P,Sgroi D,Arenzana-Seisdedos F,Delaunay T,Naeem R,Carey V,Richardson A,Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis throught elevated SDF-1/CXCL 12 secretion. Cell 2005; 121: 33548.
  • 42
    Ried S,Jäger C,Jeffers M,Vande Woude GF,Graeff H,Schmitt M,Lengyel E. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor (HGF/SF). J Biol Chem 1999; 274: 1637786.
  • 43
    Borchers AH,Steinbauer H,Schafer BS,Kramer M,Bowden GT,Fusenig N. Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma. Mol Carcinog 1997; 19: 25866.
  • 44
    Lengyel E,Gum R,Juarez J,Clayman G,Seiki M,Sato H,Boyd D. Induction of Mr 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res 1995; 55: 9637.
  • 45
    Sengupta S,Xiao YJ,Xu Y. A novel laminin-induced lysophosphatic acid autocrine loop in the migration of ovarian cancer cells. FASEB J 2003; 17: 15702.
  • 46
    Zhu G,Risteli J,Puistola U,Kauppila A,Risteli L. Progressive ovarian carcinoma induces synthesis of type 1 and type III procollagens in the tumor tissue and peritoneal cavity. Cancer Res 1993; 53: 502832.
  • 47
    Cannistra SA,Ottensmeier C,Niloff J,Orta B,DiCarlo J. Expression and function of b1 and avb3 integrins in ovarian cancer. Gynecol Oncol 1995; 58: 21625.
  • 48
    van der Wal BCH,Hofland LJ,Marquet RL,van Koetsveld PM,van Rossen MEE,van Eijck CHJ. Paracrine interactions between mesothelial and colon-carcinoma cells in a rat model. Int J Cancer 1997; 73: 88590.
  • 49
    Canis M,Botchorishvili R,Wattiez A,Mage G,Pouly J,Bruhat M. Tumor gowth and dissemination after laparotomy and CO2 pneumoperitoneum: a rat ovarian cancer model. Obstet Gynecol 1998; 92: 1048.